D. Simarmata

发表

Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection

L. Rénia, L. Ng, Y. Leo, 2012, The Journal of infectious diseases.

HLA Class I Restriction as a Possible Driving Force for Chikungunya Evolution

J. Tong, L. Rénia, L. Ng, 2010, PloS one.

The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling

T. Ahola, T. Nyman, B. Thaa, 2016, Journal of Virology.

Longitudinal Analysis of the Human Antibody Response to Chikungunya Virus Infection: Implications for Serodiagnosis and Vaccine Development

Angela Chow, Laurent Rénia, L. Rénia, 2012, Journal of Virology.

Unique Epitopes Recognized by Antibodies Induced in Chikungunya Virus-Infected Non-Human Primates: Implications for the Study of Immunopathology and Vaccine Development

L. Ng, P. Roques, Y. Kam, 2014, PloS one.

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein

J. Tong, L. Rénia, L. Ng, 2012, EMBO molecular medicine.

Early clearance of Chikungunya virus in children is associated with a strong innate immune response

L. Ng, Y. Leo, Bernett Lee, 2016, Scientific Reports.

SVM-based prediction of linear B-cell epitopes using Bayes Feature Extraction

Joo Chuan Tong, Lawrence J. K. Wee, J. Tong, 2010, BMC Genomics.